CAYLA ALEXANDER: Open Payments
NPI 1407480312 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,373 in 138 payments from 20 companies in 2025. Trend: 2023 $3,330 · 2024 $3,254 · 2025 $3,373
Food & beverage: $3,373
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $911 |
| Janssen Biotech, Inc. | 18 | $518 |
| Novartis Pharmaceuticals Corporation | 23 | $419 |
| AstraZeneca Pharmaceuticals LP | 8 | $293 |
| UCB, Inc. | 10 | $228 |
| Lilly USA, LLC | 6 | $173 |
| Amgen Inc. | 7 | $172 |
| GENZYME CORPORATION | 5 | $165 |
| PFIZER INC. | 3 | $75 |
| SOBI, INC | 2 | $60 |
Products named: RINVOQ, TREMFYA, COSENTYX, SAPHNELO, Bimzelx, SKYRIZI, KEVZARA, TALTZ.
Industry payments across WA — which companies pay providers there.
